John P. Butler - CEO and President, Director at Akebia Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and President, Director
Stock Symbol
AKBA on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

John P. Butler - trading volume in the past year for Akebia Therapeutics, Inc.

Holdings reported by John P. Butler for Akebia Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2.56M $4.68M $1.83 Mar 3, 2025 Direct
Common Stock 100K $183K $1.83 Mar 3, 2025 Held By Dorothy Butler GRAT November 2019
Common Stock 100K $183K $1.83 Mar 3, 2025 Held By John Butler GRAT November 2019
Common Stock 59.9K $110K $1.83 Mar 3, 2025 Held by Dorothy Butler 2019 GRAT
Common Stock 59.9K $110K $1.83 Mar 3, 2025 Held by John Butler 2019 GRAT
Stock Option (Right to buy) 1.05M Jan 31, 2025 Direct Common Stock
Performance Stock Units 351K Jan 31, 2025 Direct Common Stock

Transactions reported by John P. Butler for Akebia Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.